Many patients undergo diagnostic or interventional procedures in their left heart. For example a patient with atrial fibrillation may undergo an electrophysiological study inside the chambers of the left heart to determine the physical location of the source of the arrhythmia. This may require the use of electrophysiology (EP) catheters positioned in side the left heart and in contact with the walls of the heart to make electrical measurements to determine the location and propagation properties of the arrhythmia. In some instances a particular location may be an anatomic defect that can be ablated by yet another catheter system. In a similar fashion a patient may undergo left heart catheterization to receive a Left Atrial Appendage (LAA) Occlusion device that is placed in the LAA.
Although these procedures are becoming routine there is a need to improve the devices that allow the physician to gain access to the left heart from the right side of the heart and the venous system. The present standard of care involves the use of a stiff straight catheter to reach the right atrium (RA) from an entry site in the leg near the groin. Typically the venous system is accessed in the groin via the familiar Seldinger procedure. With the conventional catheter placed in the RA a supplemental and exposed needle is advanced out of the conventional catheter and it is used to approach and pierce the septal wall dividing the right heart from the left heart.
This technique is cumbersome, requires a substantial amount of fluoroscopic exposure to both the patent and the physician and is potentially dangerous of several reasons.
At the conclusion of the intervention the conventional catheters are removed and the wound in the groin is treated.
There are two outer catheters and one inner catheter described and claimed. The inner catheter may be used with either of the two outer catheters and these two combined or paired embodiments are shown and claimed.
The inner catheter can be used with conventional catheters as well but is less effective and more cumbersome to use in that configuration.
The paired catheters are useful for carrying out a method of finding and crossing the fossa ovalis and the method is described and claimed.
The two pairs of interacting devices are referred to in the specification as “Guider with Lancer” in a first embodiment and “Flexor with Lancer” in a second embodiment.
In either case the two devices are coupled together and used together to interact together to carry out steps in an electrographic location procedure or method. The inner catheter Lancer device is supported by its companion outer catheter and together they are used to electrically probe the septal wall surface to determine electrographically the location of the fossa ovalis (FO). The Lancer includes an echogenic piercing tip that may be deployed to extends from the distal tip for piecing the FO. The distal tip is sufficiently opaque to x-rays to be seen radiographically and reflective enough to be visualized using ultrasound.
With the specific FO location identified electrographically and verified with another and different modality the Lancer device may be used cross the septum with a deployable needle. Once across the septum the Guider or Flexor may be advanced into the left heart and used to approach the walls of the left atrium. When a desirable location is reached the Lancer is uncoupled from the Guider or Flexor and Lancer is withdrawn from Guider or Flexor.
Therefore in use the Guider device or Flexor device supports and places the encased Lancer device at the wall of the septum. By dragging the pair down the septal wall the FO is found with an electrographic electrode that collects EMG signal at the septum to locate the ideal location for crossing into the left heart. It is important to note that this procedure is carried out with the electrically conductive needle retracted.
With the desired treatment location found the Lancer device remains stationary and the septum is punctured with the same device. Although complex electrically and electrographically it is quicker than the conventional blind probing that is the current state of the art.
The common law trademarks Lancer, Flexor and Guider have been adopted to identify the electrographic, dilating crossing catheter Lancer, and the guiding catheters Flexor and Guider. The marks are owned by Rhythm Xience of Minneapolis, Minn.
The overall context of the invention will be described.
The structural features of Guider will be described.
The structural features of Flexor will be described.
The structural features of Lancer will be described.
The method of using Lancer with a companion device will be described.
The Lancer device is a device to perforate the septum of the heart and dilate that puncture. It is carried in the handle and adapted for sliding motion. It also has electrode connections and functions as a probing electrode. The Lancer device has an internal lumen that can support and carry a guide wire. This permits Lancer to follow over a guide wire.
Turning to
The distal assembly has three important features. The hypo-tube 128 has series of laser-machined partially circumferential slits typified by slit 130 which cooperate together to render the distal tip assembly flexible in any direction or plane and be compliant with the shape of a companion catheter. The distal tip is cut to form a piercing tip 132. This tip is electrically coupled via wire 134 to the connector generally designated 136. The distal sheath casing 122 tapers to a small diameter seen near ref numeral 138, This tapered shape serves as a dilation surface 138.
In use the physician turns the control knob with his left hand and uses the thumb of the left hand to activate the control button 228. When this button is depressed as depicted at ref numeral 230 the tooth 232 disengages from lock pinion gear 234. In the depressed or activated state the motion of the knob is unlocked and the control knob may be turned to steer or flex the distal tip of the device. When released the tooth 232 urged by spring pressure of compression spring 221.
The construction details of the invention as shown in the preceding figures are that the useable length of the distal tubular section shall be sufficient to reach from a patient's vascular insertion site, in the groin area, to the left atrium of their heart, typically 50 to 75 centimeters, but may be longer in taller patients. As is well known only the proximal and distal section of the catheters illustrated to facilitate disclosure of the invention and the inventive features in the most proximal and distal areas of the catheters. The inner diameter of the distal tubular section shall be sufficient to accommodate various catheter devices, typically 5 French (1.65 mm) to 12 French (3.96 mm). The distal tubular section shall be made of a medical grade polymer and may include wire braiding within its wall. The distal tubular section 210 shall have coatings or a biomimetic surface on its patient-contacting surfaces to provide lubricity and/or deter the formation of blood clots. The side port tube shall be made of a medical grade polymer and have an external length of approximately 5 to 20-centimeters. The mechanical deflection actuator may be configured as a rotatable wheel, rotatable coaxial collar, slide, or lever. The figures depict the control knob actuator 214 as a rotatable wheel, other actuation mechanism may be employed.
Referring now to the invention in more detail, in
In further detail, still referring to the invention of
In the
The construction details of the invention are selected such that the useable length of the distal tubular section 310; including its curved tip section 312, shall be sufficient to reach from a patient's vascular insertion site, in the groin area, to the left atrium of their heart, typically 50 to 75 centimeters, but may be longer in taller patients. The inner diameter of the distal tubular section 310, including its curved tip section 312, shall be sufficient to accommodate various catheter devices, typically 5 French (1.65 mm) to 12 French 3.96 mm). The distal tubular section 310, including its curved tip section 312, shall be made of a medical grade polymer and may include wire braiding within its wall. The distal tubular section 310, including its curved tip section 312, shall have coatings on its patient-contacting surfaces to provide lubricity and/or deter the formation of blood clots. The side port tube 316 shall be made of a medical graced polymer and have an external length of approximately 5 to 20 centimeters. The handle 314 shall be a length sufficient to efficiently manipulate the introducer with the thumb and 3-5 fingers, typically between 3-5 centimeters. Furthermore, the handle 314 shall be of shape that provides an intuitive directional indicator that is in plane with the curved tip section 312. One such shape is an inverted teardrop, as depicted in
Referring now to
The construction details of the side port tube 116, distal tubular section 110, hemostasis valve housing 124 and mounting stem 118 shown in
The advantages of the present invention include, without limitation, is that it allows the operator to efficiently torque the introducer during a procedure. Typically, the operator only has a small hemostasis valve housing to serve as a torque handle. Furthermore, by removing the side port tube from the primary area of device manipulation eliminates the risks of interfering with operation and entangling with, and possibly dislodging, an adjacent device. Finally, the addition of a biomimetic coating on the patient-contacting surfaces with mitigate the risks of thrombogenesis, or the production of blood clots, which may lead to such adverse effects as stroke, myocardial infarction, or pulmonary embolus, all of which may be fatal.
In broad embodiment, the present invention is a guiding vascular introducer designed with an ergonomic torque handle with features that promote efficient and an improved safety profile.
The stepwise sequence of use proceeds as follows:
Number | Date | Country | |
---|---|---|---|
Parent | 14715788 | May 2015 | US |
Child | 16408759 | US |